Raymond James Financial Services Advisors’s Calumet Specialty Products CLMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,131
| Closed | -$580K | – | 3460 |
|
|
2024
Q2 | $580K | Buy |
36,131
+500
| +1% | +$7.89K | ﹤0.01% | 2423 |
|
|
2024
Q1 | $529K | Buy |
35,631
+6,500
| +22% | +$104K | ﹤0.01% | 2471 |
|
|
2023
Q4 | $521K | Buy |
29,131
+9,300
| +47% | +$151K | ﹤0.01% | 2381 |
|
|
2023
Q3 | $379K | Buy |
19,831
+5,100
| +35% | +$88.3K | ﹤0.01% | 2494 |
|
|
2023
Q2 | $234K | Buy |
14,731
+1,500
| +11% | +$24.7K | ﹤0.01% | 2823 |
|
|
2023
Q1 | $230K | Hold |
13,231
| – | – | ﹤0.01% | 2812 |
|
|
2022
Q4 | $223K | Sell |
13,231
-552
| -4% | -$8.9K | ﹤0.01% | 2798 |
|
|
2022
Q3 | $177K | Buy |
13,783
+452
| +3% | +$6.48K | ﹤0.01% | 2890 |
|
|
2022
Q2 | $139K | Hold |
13,331
| – | – | ﹤0.01% | 2954 |
|
|
2022
Q1 | $181K | Sell |
13,331
-1,000
| -7% | -$14.7K | ﹤0.01% | 2995 |
|
|
2021
Q4 | $189K | Hold |
14,331
| – | – | ﹤0.01% | 2994 |
|
|
2021
Q3 | $113K | Hold |
14,331
| – | – | ﹤0.01% | 3103 |
|
|
2021
Q2 | $98K | Hold |
14,331
| – | – | ﹤0.01% | 3139 |
|
|
2021
Q1 | $87K | Buy |
+14,331
| New | +$59.8K | ﹤0.01% | 3055 |
|
|
2020
Q3 | – | Sell |
-11,289
| Closed | -$26K | – | 2903 |
|
|
2020
Q2 | $26K | Hold |
11,289
| – | – | ﹤0.01% | 2746 |
|
|
2020
Q1 | $12K | Sell |
11,289
-100
| -0.9% | -$338 | ﹤0.01% | 2383 |
|
|
2019
Q4 | $42K | Sell |
11,389
-900
| -7% | -$3.11K | ﹤0.01% | 2772 |
|
|
2019
Q3 | $45K | Sell |
12,289
-955
| -7% | -$4.08K | ﹤0.01% | 2707 |
|
|
2019
Q2 | $55K | Buy |
13,244
+1,666
| +14% | +$6.66K | ﹤0.01% | 2736 |
|
|
2019
Q1 | $41K | Buy |
11,578
+596
| +5% | +$1.98K | ﹤0.01% | 2719 |
|
|
2018
Q4 | $24K | Sell |
10,982
-5,000
| -31% | -$20.6K | ﹤0.01% | 2507 |
|
|
2018
Q3 | $102K | Buy |
+15,982
| New | +$113K | ﹤0.01% | 2659 |
|
|
2018
Q2 | – | Sell |
-10,989
| Closed | -$77K | – | 2788 |
|
|
2018
Q1 | $77K | Buy |
+10,989
| New | +$81.2K | ﹤0.01% | 2411 |
|
|
2017
Q4 | – | Sell |
-10,689
| Closed | -$89K | – | 2551 |
|
|
2017
Q3 | $89K | Sell |
10,689
-250
| -2% | -$1.56K | ﹤0.01% | 2404 |
|
|
2017
Q2 | $46K | Buy |
+10,939
| New | +$43.9K | ﹤0.01% | 2416 |
|
|
2017
Q1 | – | Sell |
-42,500
| Closed | -$170K | – | 2437 |
|
|
2016
Q4 | $170K | Sell |
42,500
-26,510
| -38% | -$108K | ﹤0.01% | 2110 |
|
|
2016
Q3 | $311K | Buy |
69,010
+600
| +0.9% | +$3.09K | ﹤0.01% | 1756 |
|
|
2016
Q2 | $335K | Sell |
68,410
-19,403
| -22% | -$110K | ﹤0.01% | 1648 |
|
|
2016
Q1 | $1.03M | Buy |
87,813
+3,217
| +4% | +$44.7K | 0.01% | 886 |
|
|
2015
Q4 | $1.68M | Sell |
84,596
-5,966
| -7% | -$147K | 0.02% | 714 |
|
|
2015
Q3 | $2.2M | Buy |
+90,562
| New | +$2.35M | 0.04% | 488 |
|
|
2013
Q3 | – | Sell |
-36,819
| Closed | -$1.34M | – | 555 |
|
|
2013
Q2 | $1.34M | Buy |
+36,819
| New | +$1.32M | 0.04% | 514 |
|
Other funds holding CLMT
WDOM
AAA
DMKJ
TCM
AFA
Raymond James Financial Services Advisors's CLMT Position: Q3 2024 in Review
Raymond James Financial Services Advisors sold out of Calumet Specialty Products (CLMT) in Q3 2024, closing a stake of 36,131 shares — an estimated $580K sold.
Raymond James Financial Services Advisors first reported a position in CLMT in Q2 2013 and held it in 32 quarters. The position peaked at $2.2M in Q3 2015. 91 funds tracked by Wall St. Rank hold CLMT as of Q3 2024.
- Raymond James Financial Services Advisors reported no remaining Calumet Specialty Products position as of Q3 2024 after selling out during the quarter.
- Raymond James Financial Services Advisors sold 36,131 Calumet Specialty Products shares in Q3 2024, an estimated $580K.
- Raymond James Financial Services Advisors first reported a position in Calumet Specialty Products in Q2 2013 and held it in 32 quarters.
- Raymond James Financial Services Advisors's Calumet Specialty Products position peaked at $2.2M in Q3 2015.
- 91 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.